The kit for Cologuard comes with everything you need for the test, including a collection tub. You don't need to do anything to prepare your body for the test. To do the test, you put a plastic ...

It’s good news in the fight against colorectal cancer: A new test ... Cologuard, can be done at home — you collect a sample of your stool and mail it to a lab with a special kit.

your plan will cover one kit every three years under Original Medicare (Parts A and B). Anyone enrolled in Medicare ages 45 years and above is eligible for coverage for one Cologuard test every ...

That’s why timely screening should be part of your regular health check-upPurdue University’s Center for Healthy Living (CHL), in conjunction with Cologuard® and Exact Sciences, is providing no-cost, ...

Many folks opt for non-invasive or at-home screening tests like Shield, the new blood test for colon cancer, or the ...

The maker of the Cologuard colon cancer screening test lowered its full-year outlook ... loss of $15.8 million or 9 cents per share in the previous quarter. Analysts surveyed by Visible Alpha ...

Cologuard Plus™ test raises the performance bar with sensitivities of 95% for colorectal cancer and 43% for advanced precancerous lesions at 94% specificity Cologuard Plus test will minimize ...

But the new, just-launched version of its Cologuard test could spur top-line growth ... that some physicians hesitated to prescribe the previous version of Cologuard because of a relatively ...

Which mold test kit is best? Mold growth in your home is more than just unpleasant. Foul odors, property damage and health complications such as asthma, skin irritation and respiratory issues can ...

Cologuard is an at-home colon cancer screening kit that detects changes in genetic material indicating potential cancer or polyps. Medicare covers one kit per year under Original Medicare (Parts A and ...

Key Takeaways Exact Sciences shares plunged Wednesday after the company reported widening losses. The maker of the Cologuard colon cancer screening test lowered its full-year outlook.CEO Kevin Conroy ...